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The gene cluster responsible for pimaricin bio-
synthesis in Streptomyces natalensis contains
a cholesterol oxidase-encoding gene (pimE)
surrounded by genes involved in pimaricin pro-
duction. Gene-inactivation and -complementa-
tion experiments revealed that pimE encodes
a functional cholesterol oxidase and, surpris-
ingly, that it is also involved in pimaricin biosyn-
thesis. This extracellular enzyme was purified
from S. natalensis culture broths to homogene-
ity, and it was shown to restore pimaricin pro-
duction when added to the mutant culture
broths. Other cholesterol oxidases also trig-
gered pimaricin production, suggesting that
these enzymes could act as signaling proteins
for polyene biosynthesis. This finding consti-
tutes the description of a cholesterol oxidase
gene with an involvement in antibiotic biosyn-
thesis, and it broadens the scope of the biolog-
ical functions for this type of oxidase.
INTRODUCTION
Streptomyces species produce a large variety of extracel-
lular enzymes, some of them clinically important, and, in
particular, cholesterol oxidases [1–4]. Cholesterol oxidase
(EC 1.1.3.6) is a flavoprotein that catalyzes both the oxida-
tion of cholesterol to 5-cholesten-3-one, with the reduc-
tion of molecular oxygen to hydrogen peroxide, and the
isomerization of the D5 bond [5], via a mechanism analo-
gous to that of the D5-3-ketosteroid isomerase from
Pseudomonas testosterini [6], to yield 4-cholesten-3-one
as the final product (Figure 1). This bifunctional enzyme
is routinely used for the enzymatic transformation of
cholesterol [7] and for determining levels of total serum
cholesterol in clinical and food specimens in a coupled
system with cholesterol esterase and peroxidase [8, 9]
(for a review, see [10]). Additionally, due to its ability toChemistry & Biology 14, 2convert cholesterol into 4-cholesten-3-one, the enzyme
disrupts the midgut epithelial membrane when it is in-
gested by larvae of some Coleoptera (e.g., Anthonomus
grandis grandis [boll weevil]) and Lepidoptera (e.g., Helio-
this virescens,Helicoverpa zea,Pectinophora gossypiella),
thus exhibiting potent insecticidal activity [11, 12].
Cholesterol oxidases have been isolated from several
sources other than Streptomyces, including members
of the genera Brevibacterium [13], Schizophyllum [14],
Burkholderia [15], and Rhodococcus [16, 17], among
others. The crystal structures of the enzymes from
Brevibacterium sterolicum and Streptomyces sp. SA-
COO have been determined at 1.8 A˚ and 1.5 A˚ resolutions,
respectively [18–20]. Most of the cholesterol oxidases are
monomeric and contain flavin-adenine dinucleotide (FAD)
as a prosthetic group [13].
Streptomyces natalensis produces pimaricin, a 26-
member tetraene, macrolide, antifungal antibiotic widely
used in the food industry in order to prevent mold contam-
ination of cheese and other nonsterile foods (i.e., cured
meat, sausages, ham, etc.), as well as for the treatment
of fungal keratitis [21, 22]. As a polyene, its antifungal
activity lies in its interaction with membrane sterols, thus
causing the alteration of membrane structure and leading
to the leakage of cellular materials. As with other macrocy-
clic polyketides, pimaricin is synthesized by the action of
so-called type I modular polyketide synthases [21].
We have previously sequenced the pimaricin biosyn-
thetic gene cluster and demonstrated its involvement in
pimaricin production by gene-disruption experiments
[23, 24]. The gene cluster encodes 13 polyketide synthase
modules within 5 multifunctional enzymes, as well as 12
additional proteins that presumably govern modification
of the polyketide skeleton, export, and regulation of
gene expression (Figure 2) [25–27]. One of these proteins,
PimE, showing a convincing sequence identity with cho-
lesterol oxidases, is encoded by a gene located in the cen-
ter of the cluster. The location of such a gene was puzzling
and prompted us to evaluate its functional role.
In this paper, we demonstrate that pimE encodes cho-
lesterol oxidase by gene disruption. The mutant obtained
by this technique lacks cholesterol oxidase and the ability79–290, March 2007 ª2007 Elsevier Ltd All rights reserved 279
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Cholesterol Oxidase Signals Pimaricin BiosynthesisFigure 1. Alignment of PimE with Other Cholesterol Oxidases
ChoA, cholesterol oxidase from Streptomyces sp. SA-COO [2]; ChoB, enzyme from Brevibacterium sterolicum [28]; ChoM, cholesterol oxidase from
Streptomyces sp. A19249 [12]. Numbers indicate amino acid residues from the N terminus of the protein (signal sequences included). The cleavage
site of the PimE signal sequence is indicated by an arrowhead. The consensus amino acid residues for FAD binding are shown in bold and are boxed
(upper alignment). The invariant Glu, His, and Asn residues (E356, H442, and N480 in mature PimE) that contribute to catalysis (see text) are also
boxed (bottom alignments). The reaction catalyzed by the cholesterol oxidase is indicated at the bottom.to produce pimaricin, suggesting that the cholesterol oxi-
dase is a key enzyme on pimaricin biosynthesis. More-
over, complementation of the mutant with pimE restored
both cholesterol oxidase activity and pimaricin biosynthe-
sis. Also, addition of purified PimE or commercial choles-
terol oxidases to the mutant broth triggered pimaricin pro-
duction, suggesting that these enzymes could act as
signaling proteins for polyene biosynthesis.
RESULTS
In Silico Analysis of the pimE Gene Product
The translated amino acid sequence of PimE (549 amino
acids) showed a very high end-to-end sequence identity
with cholesterol oxidases. These values ranged from
59% for ChoB, the cholesterol oxidase of Brevibacterium
sterolicum [28], to 82% for ChoA, the enzyme from Strep-
tomyces sp. SA-COO [2], or 91% for RimD, the enzyme
from S. diastaticus [29]. All of them show the invariant
Glu, His, and Asn residues (E356, H442, and N480 in ma-
ture PimE) that are involved in the enzyme activity [18, 30]
(Figure 1).
PimE presents a twin-arginine translocation signal se-
quence (InterPro, IPR006311) between amino acid resi-
dues 7 and 38. By analogy with other Streptomyces extra-
cellular enzymes, including other cholesterol oxidases,
this potential signal sequence was predicted to be 45
amino acids long (see below); thus, the mature enzyme
would contain 504 residues and have a molecular mass
of 54,883 Da.
The consensus sequence for FAD-binding
GxGxxGxxxAxxxxxxG [31] is located near the amino-280 Chemistry & Biology 14, 279–290, March 2007 ª2007 Elseterminal end of the mature protein at amino acids 12–28
(Figure 1). Interestingly, the third invariant Gly in the
FAD-binding motif is substituted by Ala in PimE and in
all of the previously published cholesterol oxidases from
Streptomyces. Enzymatic analyses of S. natalensis culture
broths (see Experimental Procedures) readily revealed
cholesterol oxidase activity.
Transcriptional Analysis of the pimE Gene
A previous gene-expression analysis by reverse transcrip-
tase-polymerase chain reaction (RT-PCR) of the pimaricin
gene cluster inS. natalensis ATCC27448 revealed a differ-
ent transcription profile for pimE when compared with
those of its surrounding genes (Figure 2) [26]. Such obser-
vation suggested that pimE was actually transcribed from
a monocistronic operon, in contrast with our initial as-
sumption that pimEwas a part of a large operon governing
the expression of seven genes [24]. In order to confirm this
finding, we carried out northern hybridization experi-
ments. A single RNA transcript of about 1.8 kb (data not
shown) hybridized with the probe used (see Experimental
Procedures). Given that the gene is 1650 bp in size, this
result indicates that pimE is transcribed as an indepen-
dent transcriptional unit under the culture conditions used.
Disruption of the pimE Gene
We used phage KC515, an attP-defective ØC31 derivative
[32], in order to introduce DNA into this strain. The re-
combinant phage used for pimE disruption, Ø1D3, was
constructed as described in Experimental Procedures,
and it was used to infect S. natalensis in order to obtain ly-
sogens. Because phage KC515 and its derivative lackvier Ltd All rights reserved
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Cholesterol Oxidase Signals Pimaricin BiosynthesisFigure 2. Pimaricin Biosynthetic Gene Cluster
The central section is indicated in more detail and includes a portion of an ABC transporter-encoding open reading frame (pimB), pimE (in black), an
amino transferase-encoding gene (pimC) thought to be involved in mycosamine biosynthesis, a cytochrome P450 monooxygenase-encoding gene
(pimG) and its partner ferredoxin (pimF) for electron transfer, and the 50 end of the first polyketide synthase (PKS) gene (pimS0) involved in the initiation
of pimaricinolide construction [24]. Pointed boxes indicate directions of transcription. Fragment a was used for gene disruption (see text). B, BamHI;
C, ClaI; E, EcoRI; K, KpnI; N, NotI; P, PvuII; S, SphI; V, EcoRV; Z, BglII. The inserts used for vector construction are indicated at the bottom.attP, they can only form lysogens by homologous recom-
bination into the chromosome (Figure 3A).
Several lysogens of S. natalensis were obtained by se-
lection for thiostrepton resistance and were tested for
the lack of cholesterol oxidase production. One of these
disrupted mutants was randomly selected and was
named S. natalensis D3. The identity of the mutant was
confirmed by Southern hybridization (Figure 3B). Chromo-
somal DNAs isolated from S. natalensis ATCC 27448 and
mutant D3 and digested with BglII and NcoI were probed
with the 1111 bp PvuII fragment used to construct the
KC515 derivative utilized for gene disruption (see Experi-
mental Procedures). Hybridizing bands of 2.35 kb and
1.4 kb were found for the wild-type as expected (Fig-
ure 3B). However, in the disrupted mutant, three bands
of 1.4 kb, 2.2 kb, and 11.4 kb were also detected (Fig-
ure 3B), indicating that a single crossover event had
occurred with the phage derivative. The observed hybrid-
izing bands corresponded exactly to those expected from
to the integration shown in Figure 3.
The mutant strain S. natalensis D3 showed growth and
morphological characteristics identical to those of S. nata-
lensis wild-type when grown on solid or liquid media, indi-
cating that PimE has no role on growth or differentiation of
the producer strain.Chemistry & Biology 14, 27Cholesterol Oxidase Production Is Blocked
in the pimE-Disrupted Mutant
The fermentation broth of the mutant strain generated by
phage-mediated gene disruption, S. natalensis D3, was
tested for cholesterol oxidase production. No traces of
cholesterol oxidase activity could be detected by the ex-
tremely sensitive spectrophotometric assay (see Experi-
mental Procedures), even when using 10-fold concen-
trated broths (data not shown), suggesting that PimE is
actually a functional cholesterol oxidase, and that it is
the only enzyme with such an activity produced by
S. natalensis under the experimental conditions tested.
Functional Inactivation of pimE also Blocks
Pimaricin Production
Further analysis of the disrupted mutant for pimaricin pro-
duction in complex medium (see Experimental Proce-
dures) showed that it was also blocked in the production
of the antifungal macrolide. The microbiological bioassay
against Candida utilis showed no traces of fungicidal ac-
tivity (Figure 4), as compared with that of the wild-type
strain. Furthermore, the high-performance liquid chroma-
tography (HPLC) analysis of butanol extracts from culture
supernatants indicated that no pimaricin was being pro-
duced by the mutant S. natalensis D3 (Figure 4).9–290, March 2007 ª2007 Elsevier Ltd All rights reserved 281
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Cholesterol Oxidase Signals Pimaricin BiosynthesisFigure 3. Gene Disruption of pimE
(A) Predicted restriction enzyme polymorphism caused by gene disruption. The BglII-NcoI restriction pattern before and after disruption is shown. The
probe is indicated by thick lines. The fragment used for gene disruption was fragment a from Figure 2 (see text for details). B, BamHI; C, ClaI; O, NcoI;
P, PvuII; Ps, PstI; Z, BglII.
(B) Southern hybridization of the BglII-NcoI-digested chromosomal DNA of the wild-type (lane 1) and the mutant (lane 2) strains.In order to discard any possible polar effects of gene
disruption on the transcription of other genes of the clus-
ter, RT-PCR was carried out for all of the pim genes.
Primers for RT-PCR were specific to sequences within
pim genes and were designed to produce cDNAs282 Chemistry & Biology 14, 279–290, March 2007 ª2007 Elsof 500 bp [26]. A primer pair designed to amplify
a cDNA of the lysA gene (encoding diaminopimelate de-
carboxylase) [26] was used as an internal standard of
primary metabolism genes not involved in pimaricin bio-
synthesis. All genes showed a transcriptional patternFigure 4. Disruption of PimE Blocks
Pimaricin Production, andGeneComple-
mentation Restores Antifungal Biosyn-
thesis
Comparison of HPLC analyses of butanol-
extracted broths from S. natalensis D3 (bottom)
and S. natalensis D3 transformed with pSOK-
pimE2.1 (top). Detection was carried out at
A304. Cells were grown for 48 hr at 300 rpm
and 30C in YEME medium. Bioassays for
pimaricin production, using C. utilis as test
organism, are included at the left.evier Ltd All rights reserved
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Pool Protein (mg) Activity (U)
Specific Activity
(U/mg Protein) Yield (%) Purification (Fold)
Broth 188.6 141.45 0.75 100 1
Ammonium sulfate 32.4 66.19 2.04 46.8 2.7
DEAE-FF 12.8 41.01 3.2 29 4.2
Superdex 75 3.1 37.66 12.15 26.6 16.2comparable to that of the parental strain (data not shown),
indicating that gene disruption did not have any polar ef-
fect on their transcription.
Taken together, all of these results suggest the involve-
ment of the pimE gene product in the biosynthesis of the
pimaricin molecule and constitute the first, to our knowl-
edge, indication of the involvement of cholesterol oxi-
dases in polyene macrolide biosynthesis.
Complementation of pimE-Disrupted Mutants
Restores Cholesterol Oxidase Activity
and Pimaricin Production
To confirm that the disruption of pimEwas directly respon-
sible for the observed loss of cholesterol oxidase activity
and also pimaricin production, we complemented the
pimE-disrupted mutant with pimE. A DNA fragment con-
taining pimE plus its putative promoter region was in-
serted into the self-replicating vector pSOK201 [33], giving
rise to pSOKpimE2.1 (see Experimental Procedures). The
recent development of a method for intergeneric gene
transfer from E. coli to S. natalensis by conjugation [34] en-
abled its use for the introduction of pSOKpimE2.1 into the
pimE-disrupted mutant. The plasmid was thus transferred
from E. coli ET12567 [pUZ8002] to S. natalensis D3. Intro-
duction of pSOKpimE2.1 restored cholesterol oxidase
activity in the mutant, as well as pimaricin biosynthesis
(Figure 4). These results were fully consistent with those
obtained upon disruption of the pimE gene, and they con-
firm the involvement of PimE cholesterol oxidase in pimar-
icin biosynthesis.
Purification of PimE Reveals It as an Authentic
Cholesterol Oxidase
The enzyme was purified from S. natalensis culture broths
after growth for 48 hr in YEME medium. A summary of the
specific activity and recovery of the enzyme during the pu-
rification procedure is given in Table 1. Each purification
step was also analyzed by SDS-PAGE, followed by Coo-
massie staining (Figure 5). The purified enzyme showed
a homogenous protein band on SDS-PAGE. The enzyme
was purified 16.2-fold with a yield of 26.6% from the cul-
ture broth.
The N-terminal sequence of the mature PimE protein
obtained from the gel filtration column was Arg-Ser-Gly-
Ser-Phe-Val-Pro-Ala-Val, which fully agrees with the
prediction based on sequence alignments with the se-
quence deduced from the pimE gene (see above). The
molecular mass of the mature enzyme was estimated toChemistry & Biology 14, 2be 55 kDa by SDS-PAGE (Figure 5), which is slightly
higher than the predicted value deduced from the se-
quence (54.9 kDa).
Enzymatic assays with the purified enzyme showed the
production of 4-cholesten-3-one when using cholesterol
as substrate (Figure 5), thus demonstrating that PimE is
an authentic cholesterol oxidase. The enzyme was also
able to oxidize ergosterol, albeit at a low level; 22% of
the activity observed when using cholesterol as substrate
was reached.
Exogenous Cholesterol Oxidase Restores Pimaricin
Production in pimE-Disrupted Mutants
The availability of purified PimE protein allowed its addi-
tion to culture broths of the mutant strain in order to check
its role as a putative signal protein for pimaricin biosynthe-
sis. Cells were grown in YEME medium containing in-
creasing concentrations of PimE, and pimaricin produc-
tion was assessed after 48 hr of growth. Surprisingly,
Figure 5. Purification of PimE and Determination of Its
Enzymatic Product
(A) SDS-PAGE (10% polyacrylamide) of the broth and partially purified
fractions. The gel was stained with Coomassie brilliant blue. Lanes: M,
molecular weight markers: phosphorylase b (97 kDa), bovine serum al-
bumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa),
trypsin inhibitor (20.1 kDa); 1, broth; 2, active fractions after ammonium
sulfate precipitation; 3, active fractions after anion-exchange chroma-
tography; 4, active fractions after Superdex 75 gel filtration chroma-
tography.
(B) Oxidation of cholesterol by purified PimE. The TLC migrations of
cholesterol (lane 1) and 4-cholesten-3-one (lane 3) standards are
shown. Lane 2 shows the formation of 4-cholesten-3-one after incuba-
tion of PimE with cholesterol.79–290, March 2007 ª2007 Elsevier Ltd All rights reserved 283
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Cholesterol Oxidase Signals Pimaricin BiosynthesisFigure 6. Addition of Cholesterol Oxidase to S. natalensis D3 Culture Broths Restores Pimaricin Biosynthesis
(A) S. natalensis D3 cells were grown in YEME medium, and pimaricin production was assessed after 48 hr of growth. The results of analytical HPLC
after addition of purified PimE to the culture media are shown as follows: (a) no enzyme; (b) 1.2 mg/ml; (c) 2.4 mg/ml; (d) 5.4 mg/ml; (e) 10 mg/ml PimE.
Chromatographic peaks corresponding to pimaricin are indicated by arrows. S. natalensis wild-type is included for comparative purposes. Note that
broths of the mutant strain have been concentrated 5-fold.
(B) Effect of different cholesterol oxidases on pimaricin production by S. natalensis D3. Enzymes used are: PimE, Streptomyces sp. enzyme, Cellu-
lomonas sp. enzyme, enzyme from Nocardia erythropolis, and Psesudomonas fluorescens enzyme. All enzymes were added at 10 mg/ml concentra-
tion. Pimaricin production was assessed after 48 hr of growth. Note that pimaricin production of S. natalensis ATCC 27448 under identical conditions
was 760 mg/ml. Error bars indicate the standard deviation values of the mean of three determinations.enzyme concentrations as low as 1 mg/ml in the culture
media were enough to trigger pimaricin production.
Figure 6A shows the production of pimaricin after addition
of growing concentrations of PimE enzyme to the cultures
as measured by HPLC. The identity of the pimaricin peak
was assessed by LC/MS. This unexpected result promp-
ted us to investigate whether other cholesterol oxidase
enzymes could also produce the same effect. We tested
four cholesterol oxidases (10 mg/ml) from different micro-
organisms: namely, Streptomyces sp., Cellulomonas sp.,
Pseudomonas fluorescens, and Nocardia erythropolis. In-
terestingly, all of them triggered pimaricin production to
some extent. Figure 6B shows the production of pimaricin
upon addition of the different cholesterol oxidases to the284 Chemistry & Biology 14, 279–290, March 2007 ª2007 Elseculture broth. The cholesterol oxidase from Streptomyces
sp. turned out to be the most effective, reaching levels of
72% of the pimaricin obtained with PimE. Cholesterol ox-
idase from Cellulomonas sp. also resulted in high levels of
pimaricin production (53% of the positive control). Less
effective was the addition of the enzyme from Nocardia
(14%) and that from Pseudomonas (4%). These results
provide strong evidence for a signaling role for PimE in pi-
maricin biosynthesis, and they prove that such signal can
be substituted by proteins with a similar protein structure
and equivalent enzymatic activity.
In order to test whether the effect observed was attrib-
utable to the enzymatic activity of the protein on choles-
terol, we also assayed pimaricin production after additionvier Ltd All rights reserved
Chemistry & Biology
Cholesterol Oxidase Signals Pimaricin Biosynthesisof increasing concentrations of cholesterol oxidase ca-
nonical reaction products such as H2O2 or cholestenone
(10 pM to 10 nM) to the mutant’s culture broth. However,
we could not detect any pimaricin being produced under
the conditions used (data not shown). This suggests that
the enzyme might be using a substrate other than choles-
terol during the signaling process.
We thus decided to repeat the assay with the addition of
PimE cholesterol oxidase preincubatedwith cholesterol or
ergosterol. PimE cholesterol oxidase (10 mg/ml; 20 mM)
was treated with 20 mM cholesterol or ergosterol for 10 min
at 30C, and it was then added to the cells. Pimaricin
production was assessed after 72 hr. Interestingly, pimar-
icin biosynthesis was not observed in the samples in
which the enzyme had been preincubated with ergosterol.
Although samples in which the enzyme had been preincu-
bated with cholesterol showed pimaricin production, the
production level was only 13%of that observed in the con-
trol experiment in which PimE was maintained for 10 min
at 30C in the absence of added sterols, thus indicating
that an occupied active site is not needed for the effect,
and that ergosterol and cholesterol are unlikely to consti-
tute the actual substrates for the enzyme in the signaling
process.
To discard the possibility that PimE cholesterol oxidase
acts on a medium component, the equivalent assay was
performed with resting cells. Cells were grown for 36 hr
in YEMEmedium, and they were then extensively washed
with 50 mM MOPS buffer (pH 7.2) and suspended in
the same buffer. PimE cholesterol oxidase was then
added (2.4 mg/ml), and cells were kept under agitation
for an additional 48 hr. Pimaricin production was then as-
sessed. Interestingly, pimaricin production was triggered
in the mutant, reaching 9.6 mg pimaricin/ml (data not
shown), thus suggesting that PimE either acts directly on
its cellular target (a receptor) or on a strain-specific
product.
Although results with washed resting cells corroborated
the signaling role of PimE in pimaricin biosynthesis, it
could be argued that the washing conditions used were
not sufficient to extract all sterols from the cell membrane
that may have accumulated from the medium. In order to
eliminate such a possibility, we repeated the assay by
growing cells in a minimal medium (PMM) without yeast
extract and malt extract (see Experimental Procedures).
Cells were grown for 96 hr in PMM in the presence of
10 mg/ml PimE cholesterol oxidase, and pimaricin produc-
tion was assessed every 24 hr. Although pimaricin
production by the wild-type strain in this medium is greatly
reduced when compared with that in YEME medium (only
67 mg/ml after 72 hr of incubation), we could detect pimar-
icin being produced bymutant cultures 48 hr after addition
of PimE; the amount of pimaricin produced reached
a maximum of 1.8 mg pimaricin/ml at 72 hr (data not
shown). This result excludes the possibility of PimE inter-
acting with sterols, and it corroborates our previous
conclusion.
The involvement of the enzymatic activity in the signal-
ing process was demonstrated by using cholesterol oxi-Chemistry & Biology 14, 27dase inhibitors in the resting cell signaling assay. Cells
were grown for 36 hr in YEME medium, and they were
then extensively washed with 50 mM MOPS buffer
(pH 7.2) and suspended in the same buffer containing
PimE (14 mg/ml) that had been previously treated with
2mMHgCl2 or AgNO3 for 30min at 24
C. Both salts inhibit
PimE in vitro cholesterol oxidase activity when cholesterol
is used as substrate (70% and 95%, respectively) (unpub-
lished data). Cells were then kept under agitation, and pi-
maricin production was assessed every 24 hr. Interest-
ingly, we could not detect any pimaricin being produced
in the samples that had been preincubated with the salt,
even after 144 hr of incubation, whereas in the control ex-
periment in which PimEwasmaintained for 30min at 24C
in the absence of salt, we readily detected pimaricin after
48 hr of incubation; the amount of pimaricin produced
reached a maximum of 22 mg pimaricin/ml at 96 hr, thus
indicating that the observed effect is dependent on the en-
zymatic activity of the protein.
Taken together, these results support the involvement
of PimE enzymatic activity in the signaling process, but
they do not support the possibility of an interaction be-
tween PimE and a medium component, or with putative
sterols, suggesting a direct interaction with the cells or
with a strain-specific product. The actual target for the
signal protein remains to be established.
PimE Does Not Cooperate with Pimaricin
on Antifungal Activity
In higher eukaryotes, cholesterol oxidases interact with
the membrane lipid bilayer in order to bind its steroid sub-
strate [19], and this action yields cholest-4-en-3-one,
which significantly alters the structural integrity of the
membrane [35, 36]. This production of cholestenone
from cellular cholesterol is the basis for the insecticidal
activity of cholesterol oxidases against Coleoptera [11].
Recently, it has been proposed that the tight packing in-
teraction of cholesterol and similar sterols with saturated
membrane lipids (lipid rafts) can be attributed to the prop-
erties of their small polar 3-OH group, among other factors
[36]. The small polar group could help position the sterol at
the proper depth in the bilayer to allow tight packing with
lipids, and to prevent exposure of sterol hydrocarbon to
water. The elimination of the polar OH group in the product
of cholesterol oxidase activity would therefore lead to
a more porous and less stable membrane. If this were
also true for fungal membranes in which ergosterol pro-
motes raft formation more strongly than cholesterol [37],
then PimE cholesterol oxidase could be directly involved
in weakening the structured ergosterol-lipid interactions
and thus collaborating with the antifungal action of pimar-
icin or even showing its own antifungal activity.
In order to test this hypothesis, putative antifungal activ-
ity of purified cholesterol oxidase was tested by bioassay
against C. utilis. No antifungal activity could be detected
regardless of the amount of cholesterol oxidase used
in the assays (data not shown). Similarly, we could not
detect any cooperative effect with the antifungal action
of pimaricin.9–290, March 2007 ª2007 Elsevier Ltd All rights reserved 285
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Cholesterol oxidases (EC 1.1.3.6) are enzymes produced
by a variety of microorganisms [10], including life-threat-
ening pathogens such as Rhodococcus equi,Mycobacte-
rium tuberculosis, andM. leprae [17]. Although cholesterol
oxidases have proven to be very useful for human applica-
tions that require detection or disruption of cholesterol-
containing membranes, their biological role in the cell re-
mains partly unknown. Originally, these enzymes were
found to participate in the first step of ametabolic pathway
for utilizing cholesterol as a carbon and energy source
[38]. Recently, other cellular roles have been described;
gene-disruption studies of the cholesterol oxidase gene
choE inRhodoccocus equi have indicated that cholesterol
oxidase is a major membrane-damaging factor, thus con-
tributing to pathogenicity and leading to the characteristic
lesions found in infected animals and humans [17]. In the
present study, we have used gene-disruption and -com-
plementation experiments to demonstrate that pimE en-
codes a functional cholesterol oxidase in S. natalensis,
but, more interestingly, that the encoded protein PimE is
a key enzyme in the biosynthesis of the polyene macrolide
pimaricin. To our knowledge, this finding constitutes the
first description of a cholesterol oxidase gene with an in-
volvement in antibiotic biosynthesis, and it broadens the
scope of the biological functions for this type of oxidase.
In a previous work, we found that pimE was the primary
cellular target of PimR, the pathway-specific regulator of
pimaricin biosynthesis in S. natalensis [26]. PimR is the ar-
chetype of a new, to our knowledge, class of regulators
that combines an N-terminal domain corresponding to
the SARP family of transcriptional activators, a central do-
main with similarity to the nucleotide triphosphate-binding
motif of the LuxR family of DNA-binding proteins, and a C-
terminal domain that resembles guanylate cyclases. Gene
disruption of pimR totally abrogated pimE transcription,
and it also reduced the transcription of all of the key en-
zyme-encoding genes for pimaricinolide construction to
very low levels, thus blocking pimaricin production com-
pletely and suggesting that PimE was somehow involved
in pimaricin biosynthesis [26]. The lack of pimaricin pro-
duction upon gene disruption of pimE and the recovery
of antibiotic biosynthesis upon gene complementation
further support our previous observations, and they
clearly demonstrate the involvement of PimE in the bio-
synthesis of this antifungal macrolide.
Given that PimE is a functional cholesterol oxidase of
extracellular nature, and that transcription of the remain-
ing pim genes is not affected in S. natalensis D3 mutant,
no obvious function could be predicted for it in pimaricin
biosynthesis. We thus decided to purify it in order to assay
its effect when added to the mutant cultures. Surprisingly,
addition of PimE triggered pimaricin production, and the
effect observed was dependent on the amount of the en-
zyme added. This result provides strong evidence for the
participation of PimE in a signal transduction pathway
that leads to the final production of the antibiotic. Further-
more, PimE could be substituted by other cholesterol ox-286 Chemistry & Biology 14, 279–290, March 2007 ª2007 Elseidases, including the enzymes from Streptomyces sp.,
Cellulomonas sp., Nocardia erythropolis, and the Gram-
negative bacterium Pseudomonas fluorescens, thus indi-
cating that cholesterol oxidase enzymes may fulfill a sig-
naling role in pimaricin biosynthesis. The target of these
proteins remains to be established; however, our results
discard the possibility that PimE interacts with a medium
component, and with putative sterols, suggesting a direct
interaction with the cells or with a strain-specific product.
Also, our results indicate that the signaling effect is depen-
dent on the enzymatic activity of the protein, but also that
cholesterol and ergosterol are unlikely to constitute the
actual substrates for the enzyme in the signaling process.
It is noteworthy that the Pseudomonas enzyme is able to
function as signal, although weakly, for pimaricin biosyn-
thesis in our assay system. Unfortunately, this enzyme’s
sequence is not available at the databases, but, belonging
to Pseudomonas, it is likely to have little sequence similar-
ity with Streptomyces enzymes. This would explain the
weak effect of this enzyme under our assay system. These
results now raise the question of what is the target for the
signal protein. Further experimental analyses will provide
the answer to this question.
Given that the antifungal activity of polyene antibiotics is
based on their interaction with membrane sterols, causing
the alteration of membrane structure and leading to the
leakage of cellular materials [22], it is conceivable that
PimE, besides its signaling role in antibiotic biosynthesis,
could facilitate the antifungal action of pimaricin, or even
show its own antifungal activity. The product of choles-
terol oxidase is cholestenone, which alters the integrity
of the membrane [35]. However, our results discard this
hypothesis; therefore, the results observed can only be
attributed to the involvement of PimE in a signal transduc-
tion cascade.
Computer-assisted analysis of the pimE gene product
showed a very high (more than 80%) end-to-end se-
quence identity with several cholesterol oxidases, includ-
ing ChoA and ChoM from the Streptomyces sp. strains
SA-COO and A19249, respectively [2, 12], and, interest-
ingly, with PteG, a putative cholesterol oxidase whose
encoding gene was found within the pte gene cluster of
S. avermitilis [39]. The pte gene cluster encodes the pen-
taene filipin, a 28-membered polyene macrolide very sim-
ilar in size to pimaricin. Recently, another cholesterol oxi-
dase gene (rimD) had been found to be encoded by the
gene cluster responsible for the biosynthesis of the 28-
membered tetraenes rimocidin and CE-108 in S. diastati-
cus var. 108 [29]. Although the availability of sequenced
polyene gene clusters is limited, it seems that the pres-
ence of a cholesterol oxidase-encoding gene could con-
stitute a genetic marker for the gene clusters of small-
size polyenes (26–28 members). Bearing in mind the role
of PimE in pimaricin biosynthesis, it is conceivable that
the enzymes encoded by these genes could also fulfill
a similar role in the biosynthesis of their respective poly-
ene macrolides. It is therefore plausible that the genes
that encode cholesterol oxidases might have been ac-
quired in the process of evolution by the polyene antibioticvier Ltd All rights reserved
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presence of fungi (whose cell envelopes contain ergos-
terol) in the environment via expression of the polyene an-
tibiotic biosynthesis genes.
Thus far, the presence of common regulatory circuits
controlled by cholesterol oxidase enzymes cannot be
extended to polyenes of large aglycones since no choles-
terol oxidase-encoding genes have been found in the
gene clusters for the recently characterized nystatin
[40], amphotericin [41], or candicidin [42, 43] polyene
macrolides.
SIGNIFICANCE
Polyenes represent a major class of antifungal agents
characterized by the presence of a series of conju-
gated double bonds in their planar, hydroxylated mac-
rolide ring structure. Despite their general interest,
very little is known about the factors that modulate
their biosynthesis. Thus far, only transcriptional regu-
latory genes and low-molecular weight inducers have
been found to be involved inmacrolide regulation. This
report describes an authentic cholesterol oxidase (en-
coded by pimE of the pimaricin cluster), an extracellu-
lar enzyme traditionally considered to have a nutri-
tional role in bacteria, as an essential element for the
biosynthesis of the tetraene pimaricin. The discovery
of the involvement of cholesterol oxidases in a signal
transduction cascade for the production of polyenes
is totally unexpected, and it broadens the scope of
the biological functions for this type of oxidase. Addi-
tional experiments that examine the precise mecha-
nism by which cholesterol oxidase modulates polyene
biosynthesis will aid in the understanding of the mo-
lecular mechanism of signal transduction.
EXPERIMENTAL PROCEDURES
Materials
Sepharose Q XL, Superdex 75 columns, and Mr standards for SDS-
PAGE were obtained from Amersham Pharmacia Biotech; ProBlott
polyvinylidene difluoride membranes and sequencing reagents were
obtained from Applied Biosystems, Inc. Commercial cholesterol oxi-
dases were obtained from Pseudomonas fluorescens, Streptomyces
sp., Cellulomonas sp. (Sigma), and Nocardia erythropolis (Fluka). All
other reagents were obtained from commercial sources and were of
analytical grade.
Bacterial Strains, Cloning Vectors, and Cultivation
S. natalensis ATCC 27448 was routinely grown in YEME medium [44]
without sucrose. Sporulation was achieved in TBO medium [24]. For
pimaricin production, the strain was grown in YEME medium without
sucrose, as described elsewhere [25]. The minimal medium used for
pimaricin production was PMM (MgSO4$7H2O, 0.2 g/l; FeSO4$7H2O,
0.01 g/l; CaCl2, 1 g/l; MOPS, 2 g/l [pH 7.0]; L-asparagine, 2 g/l; glu-
cose, 20 g/l; glycerol, 5 g/l; KH2PO4+K2HPO4, 1 mM; CuSO4$5H2O,
0.7 mM; H3BO3, 0.4 mM; MnSO4$H2O, 0.12 mM; ZnSO4$7H2O, 14 mM;
(NH4)6Mo7O24$4H2O, 0.013 mM). The same media were supple-
mented with thiostrepton when used for S. natalensis D3 growth
and/or metabolite production. Escherichia coli strain XL1-Blue MR
(Stratagene) was used as a host for plasmid subcloning in plasmids
pBluescript (Stratagene), pUC18, and pUC19. C. utilis CECT 1061Chemistry & Biology 14, 2was used for bioassay experiments. Phage KC515 (c+ attP::tsr::vph),
a ØC31-derived phage [32], was used for gene-disruption experi-
ments. Streptomyces lividans JII 1326 [45] served as a host for phage
propagation and transfection. Infection with Ø1D3 (the KC515 re-
combinant derivative used for gene disruption) was carried out in R5
medium [44]. Standard conditions for culture of Streptomyces species
and isolation of phages were as described by Kieser et al. [44].
Genetic Procedures
Standard genetic techniques with E. coli and in vitro DNA manipula-
tions were as described by Sambrook and Russell [46]. Recombinant
DNA techniques in Streptomyces species and isolation of Streptomy-
ces total and phage DNAwere performed as previously described [44].
Southern hybridizations were carried out with probes labeled with di-
goxigenin by using the DIG DNA labeling kit (Roche). Intergeneric con-
jugation between E. coli ET12567 [pUZ8002] and S. natalensis was
performed as described [34].
Isolation of Total RNA and Northern Analysis
S. natalensis ATCC 27448 was grown for 48 hr in YEME medium with-
out sucrose (stationary phase of growth), the cultures were then mixed
with one volume 40% glycerol, and mycelia were harvested by centri-
fugation and were immediately frozen by immersion in liquid nitrogen.
Frozen mycelia were then broken by shearing in a mortar, and the fro-
zen lysate was added to buffer RLT (QIAGEN) in the presence of 1.5%
b-mercaptoethanol. RNeasy Mini Spin columns were used for RNA
isolation according to the manufacturer’s instructions. RNA prepara-
tions were treated with DNase I (Promega) in order to eliminate possi-
ble chromosomal DNA contamination. After separation in denaturing
agarose gels, the RNA was transferred to nylon membranes. Northern
hybridization was performed by standardmethods [46] with a 1,111 bp
PvuII probe internal to pimE.
Construction of a pimE Mutant
The pimE gene was disrupted by KC515 phage-mediated single-
crossover integration as follows: A 7.6 kbNotI fragment encompassing
most of the pimE gene (lacking 107 bp from the 50 end of the gene),
pimC, pimG, pimF, and part of the pimS0 gene (Figure 2) was cloned
into a NotI-cut pBluescript vector to yield p980n1. This plasmid was
then used as a source of DNA for gene disruption. A 1,111 bp PvuII
fragment (fragment ‘‘a’’ in Figure 2) was ligated into a SmaI-cut pBlue-
script, whichwas subsequently cut with BamHI and PstI (both sites be-
long to the polylinker), and the resulting fragment was then cloned into
the BamHI-PstI sites of KC515. Due to the absence of SacI sites within
the insert, the recombinant phages were selected by digestion of the
ligation mixture with SacI (KC515 is susceptible to digestion, while
KC515 derivatives are resistant). Transfection ofS. lividans protoplasts
resulted in a number of phage plaques that were screened by Southern
hybridization for the presence of pimE-derived sequences. One of the
recombinants, Ø1D3, was selected and used to infect S. natalensis,
thus allowing the selection for lysogen formation. Lysogens were se-
lected by thiostrepton resistance on R5 medium [44] and were con-
firmed by genomic Southern hybridization.
Complementation of pimE
In order to complement pimE deletion mutants, a 6.9 kb SphI fragment
containing the entire pimE gene, including its own promoter, pimC,
pimG, pimF, and part of the pimS0 gene (Figure 2), was cloned into
a SphI-cut pUC vector to yield pJA1. This plasmid was then digested
with BamHI (one of the sites belonging to the polylinker), and the result-
ing 2,992 bp fragment was ligated into a BamHI-cut pSOK201 (NeoR,
AmR, ColE1 + pSG5 replicons [33]) to yield pSOKpimE2.1. This plas-
mid was then transferred by conjugation from E. coli ET12567
[pUZ8002] to the S. natalensis pimE-disrupted mutant (D3) as previ-
ously described [34].79–290, March 2007 ª2007 Elsevier Ltd All rights reserved 287
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Cholesterol oxidase activity was assessed as described previously [9].
The assay mixture contained 50 mM potasium phosphate (pH 7.0),
5 mM sodium cholate, 1 mM cholesterol, 7 mM phenol, 1.4 mM 4-ami-
noantipyrine, 0.33%Triton X-100, and 7U horseradish peroxidase. For
determination of cholesterol oxidase activity, the appearance of quino-
neimine dye, which is formed by the reaction with 4-aminoantipyrine,
phenol, and peroxidase, was measured espectrophotometrically at
500 nm. One unit of activity was defined as the formation of 1 mmol hy-
drogen peroxide (0.5 mmol of the red dye) per min at pH 7.0 and 37C.
Assay of Pimaricin Production
Culture broths were extracted with butanol and processed as previ-
ously described [25]. To confirm the identity of pimaricin, a UV-visible
absorption spectrum (absorption peaks at 319, 304, 291, and 281 nm)
was routinely determined in a Hitachi U-2001 spectrophotometer. The
fungicidal activity of pimaricin was tested by bioassay by usingC. utilis
CECT 1061 as the test organism. Quantitative determination of pimar-
icin was performed with a Waters 600 HPLC with a diode array ultravi-
olet detector set at 304 nm, fitted with a m-Bondapack RP-C18 column
(10 mm; 3.9 3 300 mm). Elution was performed with a gradient
(1 ml/min) of 100% methanol (methanol concentration: 50%, 0–3 min;
up to 90%, 3–12 min; 90%, 12–20 min; down to 50%, 20–25 min;
50%, 25–30 min). Retention time for pimaricin was 14.5 min. HPLC-MS
assays were carried out on an LC-TOF (Micromass) by using electro-
spray as the source and the positive ionization mode.
Gene Expression Analysis by RT-PCR
Transcription was studied by using the SuperScript One-Step RT-PCR
systemwith Platinum Taq DNA polymerase (Invitrogen); 5 ng total RNA
was used as template. Conditions were as follows: first-strand cDNA
synthesis, 45C for 40 min, followed by 94C for 2 min; amplification,
28 cycles of 98C for 15 s, 60C–70C (depending of the set of primers
used) for 30 s, and 72C for 1 min. Primers (18- to 24-mer) were de-
signed to generate PCR products of 500 bp [26]. Negative controls
were carried out with each set of primers and Platinum Taq DNA poly-
merase in order to confirm the absence of contaminating DNA in the
RNA preparations. The identity of each amplified product was corrob-
orated by direct sequencing with one of the primers.
Cholesterol Oxidase Purification
All purification procedures were carried out at 4C. S. natalensis ATCC
27448 was grown in YEMEmedium and the broth collected after 48 hr.
Cells were removed by filtration under vacuum, and the broth (1320ml)
was used as the source of enzyme.
Step 1: Ammonium Sulfate Fractionation
Ammonium sulfate was added in order to bring the concentrated broth
to 70% saturation, and the mixture was stirred overnight at 4C. After
centrifugation, the pellet was dissolved in buffer A (50 mM Tris-HCl
[pH 7.0], 1 mM EDTA, 1 mM 1,4-dithiothreitol).
Step 2: Anion-Exchange Chromatography
The enzyme solution (32.4mgprotein and 141.45U of enzyme in 440ml)
was dialyzed against buffer A. Then, it was divided into two aliquots,
and each aliquot was applied to a DEAE-FF column (1 cm 3 5 cm,
5 ml) equilibrated with buffer A (flow rate of 1 ml/min). The column
was washed with 50 ml of this buffer. The cholesterol oxidase enzyme
did not bind to the column. This solution was then concentrated in Ami-
con Ultra 15 concentrators. The final volume of pooled active fractions
was 120 ml (12.8 mg of protein, 41.01 U).
Step 3: Superdex 75 Chromatography
The former solution was used as the source of material for size-exclu-
sion chromatography. For each chromatography, 2 ml of the former
enzymatic preparation was applied (flow rate of 0.1 ml/min) to a Hi
Load 16/60 Superdex 75 column (1.6 cm3 60 cm; 120ml) equilibrated
with buffer A containing 150 mM NaCl and 5 mM sodium deoxycho-
late. In the absence of sodium deoxycholate, the oxidase eluted over
a wide range of fractions and was not separated from impurities. Frac-
tions were collected and assessed for the presence of cholesterol288 Chemistry & Biology 14, 279–290, March 2007 ª2007 Elseoxidase by SDS-PAGE. The final volume of the pooled cholesterol
oxidase-pure fractions was 54 ml (3 mg protein, 37.66 U).
Analytical Methods
Protein concentrations were estimated by using the Bradford method
[47] or by measuring the absorbance of column eluates at 280 nm.
SDS-PAGE was performed on 10%–12% polyacrylamide gels by fol-
lowing standard procedures. After electrophoresis, gels were stained
either with Coomassie brilliant blue R-250 or with silver. Alternatively,
gels were transferred to ProBlott polyvinylidene difluoride membranes
according to Matsudaira [48] and were subjected to Edman degrada-
tion on an Applied Biosystems 477A pulsed-liquid protein sequencer.
TLC plates (Silica Gel G-60, Merck) were developed in a mobile phase
of toluene/ethyl acetate/formic acid (80:20:5 vol/vol/vol), and com-
pounds were stained with 20% phosphomolibdic acid in ethanol.
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